MXCT: MaxCyte, Inc. Stock

SIC 8731 – Commercial Physical and Biological Research

Valuation
Market Cap ($M) 400.31
Enterprise Value ($M) 353.80
Book Value ($M) 232.17
Book Value / Share 2.22
Price / Book 1.72
NCAV ($M) 154.09
NCAV / Share 1.47
Price / NCAV 2.60

Profitability (mra)
Return on Invested Capital (ROIC) -0.15
Return on Assets (ROA) -0.13
Return on Equity (ROE) -0.15

Liquidity (mrq)
Quick Ratio 9.97
Current Ratio 10.65

Balance Sheet (mrq) ($M)
Current Assets 190.19
Assets 268.27
Liabilities 36.11
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 41.29
Operating Income -48.30
Net Income -37.92

Cash Flow Statement (mra) ($M)
Cash From Operations -21.69
Cash from Investing 54.98
Cash from Financing 2.14

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
03-25 13G Integrated Core Strategies (us) Llc 5.50 14.70
02-14 13G Cadian Capital Management, Lp 5.50
02-14 13G/A Casdin Capital, LLC 0.00 -100.00
02-13 13G Vanguard Group Inc 5.09
01-26 13G/A BlackRock Inc. 8.00 6.88

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-12 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-03 66,006 405,397 16.28
2024-05-02 72,185 419,366 17.21
2024-05-01 115,974 281,209 41.24
2024-04-30 138,580 211,491 65.53
2024-04-29 40,299 130,443 30.89

(click for more detail)

Similar Companies
ABSI – Absci Corporation ICLR – ICON Public Limited Company
INCY – Incyte Corporation MEDP – Medpace Holdings, Inc.
NRC – National Research Corporation


Financial data and stock pages provided by
Fintel.io